[Translation] A single-center, open-label, randomized, single-dose, four-period, two-sequence, fully repeated crossover bioequivalence study to evaluate the test preparation menatetrenone soft capsule (specification: 15 mg) and the reference preparation Gulikang® (specification: 15 mg) in healthy Chinese adult subjects in the fasting and fed state
主要研究目的:研究空腹和餐后状态下单次口服受试制剂四烯甲萘醌软胶囊(规格:15 mg,持证商:昆明邦宇制药有限公司)与参比制剂四烯甲萘醌软胶囊(固力康®,规格:15 mg,持证商:Eisai Co.,Ltd.)在健康受试者体内的药代动力学特征,评价空腹和餐后状态口服两种制剂的生物等效性。
次要研究目的:评估受试制剂四烯甲萘醌软胶囊(规格:15 mg)和参比制剂四烯甲萘醌软胶囊(固力康®,规格:15 mg)在健康受试者中的安全性。
[Translation] The main purpose of the study is to study the pharmacokinetic characteristics of the test preparation tetrafenone soft capsule (specification: 15 mg, licensee: Kunming Bangyu Pharmaceutical Co., Ltd.) and the reference preparation tetrafenone soft capsule (Gulikang®, specification: 15 mg, licensee: Eisai Co., Ltd.) in healthy subjects after a single oral administration in the fasting and fed state, and to evaluate the bioequivalence of the two preparations in the fasting and fed state.
Secondary purpose of the study is to evaluate the safety of the test preparation tetrafenone soft capsule (specification: 15 mg) and the reference preparation tetrafenone soft capsule (Gulikang®, specification: 15 mg) in healthy subjects.